FDA approves Merck’s Keytruda plus chemotherapy as first line treatment for locally advanced Metastatic HER2-Negative Gastric

Approval based on results from the Phase 3 KEYNOTE-859 trial, which demonstrated significant improvement in overall survival in these patients versus chemotherapy alone

GenWorks Health & Rotary Club partners to transform rural healthcare

GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities

Glenmark to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 diabetes

Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery

Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune

UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK

Sir H. N. Reliance Foundation Hospital launches Sepsis Cart

The hospital hosted a two-day event with top internal and external faculty and medical experts

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris

Global health challenges can be resolved using digital technology: Dr Alain Labrique

European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ

KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population

Apollo’s Apollo Connect program bets big on expanding access and elevating care

Aims to build the largest connected healthcare ecosystem in India